Siemens Healthineers (XTRA:SHL) is reviewing options for its Diagnostics business, including a possible sale. The review follows moves by Siemens AG to reduce its majority stake in Siemens Healthineers. Any decision could reshape the company’s business mix within the global healthcare diagnostics market. Siemens Healthineers operates across imaging, diagnostics and related healthcare technologies, giving it a broad role in hospital and lab workflows. A potential change in the Diagnostics…Read More
Siemens Healthineers Diagnostics Review Puts Valuation And Business Mix In Focus
Related Posts
Add A Comment
